Meet Inspiring Speakers and Experts at our 3000+ Global Events with over 1000+ Conferences, 1000+ Symposiums and 1000+ Workshops on Medical, Pharma, Engineering, Science, Technology and Business.

Explore and learn more about Conference Series : World’s leading Event Organizer

Conference Series Conferences gaining more Readers and Visitors

Conference Series Web Metrics at a Glance

  • 3000+ Global Events
  • 100 Million+ Visitors
  • 75000+ Unique visitors per conference
  • 100000+ Page views for every individual conference

Unique Opportunity! Online visibility to the Speakers and Experts

Recommended Global Immunology Webinars & Conferences

Europe & UK

Asia Pacific & Middle East

Canada

HIV-AIDS-Summit

About Conference:-

Welcome to the Inrnational Congress on HIV-Aids and STD's and also join the webinar during January 03-04, 2023HIV-AIDS-SUMMIT is being organized with the association Journal of HIV-Current Research.

Theme of the webinar highlights “Raising Global Awareness on STD/AIDS and Fighting the Stigma Surrounding the Syndrome Scientific Tracks designed for this webinar will enable the attendees and participants to learn extremes.

Objective:

• Developing new AIDS medicines

• Antimicrobial resistance in HIV patients

• HIV Infection and its Consequences

• HIV Aging and Its Health Problems

• Sexually transmitted diseases (STDs), also called sexually transmitted infections (STIs), are infections that spread from person to person through sexual activity, including anal, vaginal, or oral sex.

Sessions and Tracks:-

Track 01-AIDS stigma and discrimination:-

HIV shame and compartmentalization can be multifaceted deterrents to containment, testing, treatment, and maintenance for individuals who have or are at risk for HIV. A few traces of shame do not allow them to be shunned by the household, the nobility, and the wider community; get down and out of treatment in well-being care and encounter basic self-confidence, insufferability or exasperation.

Several substances with HIV were denied or lost shops, accommodation and other organizations avoided receiving welfare care. They were denied access to teachers and programs and were victims of brutality and heinous offences. HIV-related shame and isolation predicts that people learn their HIV status, unquestioningly illuminate their status to family accomplices and sexual accessories, and get remedial care and treatment, weakening their ability to secure themselves from HIV infection or transmission and remain sound. HIV-related shame is more complex when individuals more

Track 02-Viral, Bacterial, Fungal & Protozoan STDs:-

Viral sexually transmitted diseases are caused by human-to-human and dependent on sexually transmitted diseases, they can be transmitted during sexual movement, amid non-sexual contact with an extra individual, from mother to child amid pregnancy, childbirth or breastfeeding, blood transfusion or spread.

Pour from the device and in several cases from a shower towel, straw or other objects that come into contact with the affected person. Viral sexually transmitted diseases include cytomegalovirus, genital warts / human papillomavirus (HPV), hepatitis (A, B and C), herpes (HSV1 and HSV2), HIV (differentiates), Mollusca Contagious, mononucleosis ("Mono"), etc. Bacterial sexually transmitted diseases communicable diseases are caused by organisms driven from person to person by sexual development. STDs caused by infinitesimal living things consolidate, Chlamydia (Chlamydia trachomatis) Gonorrhea (Neisseria gonorrhea) Granuloma inguinal (Calymmatobacterium granulomatis) chanchroid etc.

Track 03-Lived experience of HIV:-

HIV, by measurement, is a deep-seated, rather than a fatal, disease. Professionals are aware of much more nearly the direction of HIV than they were a long time ago. But patients living with HIV still face different errands. Some of these are energy issues, for example patients may still face division due to confusion about how HIV is transmitted. People who have a psychiatric condition or who abuse drugs or alcohol are still the least likely to follow through with treatment

Currently, Decidedly Living & Astounding Wellbeing Organization operates as a non-profit organization serving East Tennessee's most vulnerable residents, approximately 5,000 individuals and families engaged in surviving the challenges of HIV, homelessness, mental illness, substance abuse and disability.

Track 04- HIV and AIDS Nursing Care Management:-

Health care providers have a vital role in the care of people with HIV, from providing data and strengthening recent resolve to providing advice on treatment and common well-being issues Health care providers often have more time than masters to talk to people about problems and can be way better clarify what the expert said in a dialect that the silent will recognize.

Patients who call THTs for advice are now and then numb that therapeutic nurses can provide help at this level. Patients are generally satisfied with the reinforcement from doctors and report disclosure, making it easier to discuss with therapeutic paramedics. In addition, therapeutic caregivers are monotonously involved in HIV testing, involving and empowering decisions about whether to test, conducting blood tests, and giving reminders and information to people who are HIV positive.

Track 05 -Pediatric HIV AIDS:-

More than 90% of HIV infections in children are due to mother-to-child transmission, which occurs when an HIV-positive mother passes the virus to her child during the perinatal period, during childbirth or breastfeeding. The likelihood of this type of transmission increases directly with the severity of the mother's HIV contamination.

Offspring living with HIV are exterminated more ruthlessly than adults because their immune systems are not fully formed. They may be exposed to the same common pediatric contamination as HIV-negative youngsters, but they will not be able to combat them as viable. Ear and sinus infections, sepsis, pneumonia, TB, urinary tract disease, duodenal disease, skin disease and meningitis are all common infections among HIV-positive young people. Tuberculosis, runs and respiratory diseases are common among HIV-positive children in the formation of nations.

Track 06 -HIV and Retroviral Diseases:-

A retrovirus can be a type of virus belonging to the Retroviridae family that transmits its genetic outline within ribonucleic acid (RNA). Retroviruses are named after the enzyme reverse transcriptase, which was discovered by American virologists Howard Temin and David Baltimore in 1971. A switch transcriptase can be a protein that switches via RNA to deoxyribonucleic acid (DNA), thereby altering the normal course of cellular translation (DNA to RNA) Since the switch transcriptase operation, the heritable structure from the retrovirus has the potential to enter the DNA genome of the infected cell forever.

In the organic sciences, protein is widely used to combine properties. Human immunodeficiency infection (HIV) could be a retrovirus that causes acquired immunodeficiency disorder (Helps) in humans. Simian immunodeficiency virus (SIV), a retrovirus prevalent in chimpanzees and gorillas, is closely related to HIV.

Tack 07 ­­­-HIV Testing:-

An antigen/antibody test performed by a laboratory on blood from a vein can usually detect HIV 18 to 45 days after exposure. There is also a rapid antigen/antibody test that is done with a finger stick. Antigen/antibody tests performed on finger stick blood may take 18 to 90 days after exposure.

Antigen/antibody tests are recommended for laboratory testing and are common in the United States. This lab test involves drawing blood from a vein. A rapid antigen/antibody test is also available, which is done using blood from a fingers tick.

Track 08- HIV Drug Discovery and Research:-

The initial proficiency of combinatorial antiretroviral therapy in the treatment of HIV contamination has been co-operated to some extent by quick growth of multidrug-resistant HIV strains, poor bioavailability, and accumulative toxicities, and so there's a require for elective procedures of antiretroviral sedate disclosure and additional helpful specialists with novel action strategies or targets. From this discernment, we to begin with audit later procedures of antiretroviral drug revelation and optimization, with the aid of selected examples from the later literature.

We highlight the extension of phosphate ester-based prodrugs as means to improve the fluid solubility of HIV inhibitors, and the introduction of the substrate envelope speculation as a new approach for overcoming HIV drug resistance. Lastly, we discuss future guidelines for investigate, including opportunities for misuse of novel antiretroviral targets, and the approach of enactment of inactive HIV stores as a implies to extremital

Track 09 -HIV/AIDS Nursing and AIDS awareness:-

HIV can be spread through blood transfusions, while 97 percent of them knew it could be transmitted through unsterilized needles and syringes. Common misconceptions among defendants about HIV/AIDS were HIV transmission through hugging, sharing can seats, towels, utensils, shaking hands, and even mosquito bites. Out of a total of 95 nursing students who realized that AIDS could be avoided by changing their behavior, 60 percent of them felt it was vital to be reliable to their life partner.

70 percent of them knew that blood transfusion-related infection can be reduced by blood testing. More than 60 percent of students said that television is the best way to inform the public, followed by posters, radio, etc.

Track 10 -Venereal Diseases Prevention and Treatment:-

The event of persistent disease complications in controlled HIV disease changed the landscape of clinical HIV care. HIV disease provides the possibility of advancing cardiovascular disease, which is thought to be caused by a complex interaction of modifying variables. While the usual components of cardiovascular risk likely play a role, HIV-related irritation and safe sanctions were later shown to be a critical transition between cardiovascular risks.

It is unclear whether established preventive distractions for the general population are relevant to HIV-infected patients, and the ability to decode foolproof information into HIV-specific clinical mediations speaks to a fundamental need. Established techniques to avoid cardiovascular disease in HIV-infected persons require a multidisciplinary approach and speak to the opportunity to exert a large open effect on well-being in at-risk populations.

Track 11- HIV and cardiovascular disease:-

The event of persistent disease complications in controlled HIV disease has changed the landscape of HIV clinical care. HIV infection provides an opportunity to advance cardiovascular disease, which is thought to be caused by a complex interaction of modifying factors. While common components of cardiovascular risk likely play a role, he later demonstrates that HIV-related disruption and safe sanctions are the fundamental transition between cardiovascular risks.

It is questionable whether the established prevention interventions for the general masses are relevant to HIV-infected patients, and decoding the dumb data into HIV-specific clinical mediation conversations is a fundamental requirement. Established strategies to avoid cardiovascular disease in HIV-infected persons require a multidisciplinary approach and speak to the opportunity to exert a large open influence on prosperity in at-risk populations

Track 12- HIV and bone damage:-

The bones are tilted to urge the weaker as you get more seasoned. This will be overwhelmingly honest on the off chance that you simply got Human Immunodeficiency (HIV) infection. The infection that causes Helps itself can make your bones more likely to break. And several HIV medications can increase your chances of bone loss. Over time, this can cause your bones to turn soft.

If you also lose a lot of bone mass or thickness, your specialist may identify you with osteoporosis. A milder degree of bone incident is called osteopenia. Almost half of all people with HIV develop osteoporosis or osteopenia. They are twice as likely to break a bone than those who do not suffer from the disease. Many things can play a role in increasing the risk of bone thickness and fractures.

Track 13 -HIV and Aging:-

Adolescent individuals with HIV share numerous of the same prosperity concerns as the general population who reach 50 and over experienced: - numerous entrenched diseases or conditions use numerous solutions, changes in physical and cognitive abilities, and widespread defenselessness to stressors. In addition, although viable HIV treatment has reduced the likelihood of AIDS-defining illnesses in individuals maturing with HIV, more experienced people with HIV regularly develop numerous non-HIV-related conditions such as cardiovascular infection, diabetes, kidney infection, and more. cancer.

These conditions are likely related to a number of cooperating variables that control persistent HIV deterioration. Analysts are working to better understand what causes obstinate exacerbation, in fact, when people are treated with craftsmanship.

Track 14 -HIV in women:-

The first common way women get HIV is having sex with a male accessory who has HIV without using a condom. HIV is spread through blood, pre-seminal fluids, semen, vaginal fluids, rectal fluids and breast drainage. Having anal or vaginal sex with a person who has HIV without using a condom or taking drugs to keep a strategic distance from HIV or to treat HIV. Anal sex is a dangerous type of sex to get HIV because the lining of the anus is tilted and can allow HIV to enter the body during anal sex. Sharing mixtures and medical equipment such as needles with a person who has HIV.

Track 15- HIV Diagnosis and Therapy:-

The specialist will talk about it and come up with a treatment plan to help you fight the virus. Initial testing can also alert you to high-risk practices that could spread contamination to others. The majority of health workers carry out HIV testing, which is often accompanied by satisfactory counselling. Testing is additionally open in a mysterious and free arrangement. After the tests are complete, your doctor will ask about your symptoms, medical history, and random factors, as well as perform a physical exam

Track 16- Emerging Technologies towards HIV/AIDS:-

In the past decade, the topic of technology-enabled HIV research and prediction has emerged as a vibrant, energetic division with tremendous promise to help bring HIV prevention initiatives to high-risk populations. The development of technology and the HIV epidemic point to new approaches to reach the most vulnerable groups. The disruptors and administration that humans now provide cannot be completely replaced by new advances.

In any case, we believe that growing technologies have the ability to scale administration and ensure efficiency in reaching out to rustic MSM communities, binding to people not reached by current metropolitan activities, and advertising algorithmically indicated services or asking about projects.

Track 17 -HIV & Vaccines:-

Over the past 30 years, HIV treatment options have improved significantly. However, drugs can have negative side effects, be expensive and difficult to obtain in some countries. Some people may develop drug resistance to a particular HIV treatment, requiring them to change regimens. HIV transmission can be avoided by appropriate condom use and pre-exposure prophylaxis.

However, scientists believe that the most effective course of action to completely eradicate modern HIV infections is to develop a prophylactic HIV vaccine. 1. Covid-19 2. Hepatitis B is the second most common type of hepatitis. 3. Human papillomavirus (for people under 26) 4 Influenza virus (flu) 5 Meningococcal vaccines to prevent meningococcal disease 6 Pneumococcal infection (pneumonia) 7 Whooping cough, tetanus and diphtheria (whooping cough). All three diseases are covered by a single vaccine.

Track 18- Viral Immunology and Vaccines development:-

Vaccines are one of the most critical triumphs of modern medicine. Later advances in natural resistance brought new insights into the mechanisms of vaccine-induced resistance, allowing for a more rational approach to antibody design. Viruses remember a wide range of human diseases, from common ailments like the flu to new contaminations. Anyone interested in developing or spreading antibodies to fight these diseases must first understand how the immune system prevents and kills viral infections.

Track 19 -Awareness and knowledge on HIV/AIDS, STDs and STIs:-

The human immunodeficiency virus (HIV) has evolved as a most pressing public health and human rights issue. One of the primary tactics used to prevent and control HIV/AIDS around the world is to spread knowledge and awareness about this infection. Inadequate data and dangerous bugs are important deterrents to prevent HIV transmission. Sexually transmitted diseases (STDs) and unwanted pregnancies are common among youth in many countries.

By the age of 15, a significant proportion of young people in many countries have started sexual activity. Young people are thus generally more at risk of contracting HIV through sexual transmission. More than one in five modern analyzes were performed by children aged 13–14.

Tack 20-Side effects of HIV:-

Most individuals infected with HIV experience a brief flu-like illness that occurs 2-6 weeks after contamination. After that, HIV may not cause any side effects for a long time. Up to 80% of individuals who are affected by HIV are diagnosed with this flu-like illness. HIV can be an infection that weakens your immune system. It is exchanged through actual fluids such as semen, vaginal fluids and blood.

Market Analysis:-

The fact that HIV infection and AIDS have become a major global public health problem is now accepted. The significance, risk, and expense of HIV/AIDS cannot be overstated or minimised. While we are fortunate that, at least for The United States and Europe the apocalyptic predictions of the mid-1980s have not come to pass. HIV/AIDS continues to have a huge impact on global society.

While HIV/AIDS does not make the news as frequently as it did when it was first discovered, more people in the United States are living with the disease than ever before. While the prevalence of HIV infection in the United States was around 0.25 percent of the population ten to fifteen years ago, it is currently at 0.47 percent, and the population has expanded in general.

As a result, it's critical to comprehend HIV/AIDS epidemic patterns and their possible consequences for economies and communities.

From USD 2.35 billion in 2016, the HIV diagnostic market is expected to grow at a CAGR of 10.5 percent to USD 3.88 billion by 2021. The market is predicted to develop due to factors such as the rising global prevalence of HIV/AIDS, the rising number of blood transfusions and blood donations, the benefits provided by point-of-care tools and kits, and increased government initiatives. The study's base year was 2015, and the projection was made for the years 2016 through 2021.

HIV is a sexually transmitted infection, but it can progress to a disease called acquired immunodeficiency syndrome (AIDS) when HIV infection is untreated. Other examples of STDs are chlamydia, gonorrhea, human papillomavirus (HPV) infection, and syphilis.

Benefits of participation:-

Advantages of Participating at our Webinar

  • The advantages of the Speaker and abstract pages are created in Google on your profile under your name would get worldwide visibility.
  • Our comprehensive online advertising attracts 30000+ users and 50000+ views to our Library of Abstracts, which takes researchers and speakers to our webinar.
  • Meet with hundreds of like-minded experts who are pioneers in HIV-Aids and STD's and share ideas.
  • All participants in the webinar would have a different reason to participate with eminent speakers and renowned keynote speakers in one-to-one meetings.
  • A rare opportunity to listen what the world's experts are learning about from the world's most influential researchers in the area of Public Health at our Keynote sessions.
  • STD's HIV-Aids and Summit intensive webinar schedule, you will acquire experience and expertise in strategic gift preparation that is worth its weight golf, forming an impressive array of recognised professionals.
  • Best Poster Award nominations.
  • Award for Outstanding Young Researcher.
  • Group Registration Advantages.

Benefits of Participation for Speaker

  • Worldwide appreciation of the profile of Researchers.
  • Obtain credits for professional growth.
  • Explore the latest of cutting edge analysis.
  • Make long-term bonds at social and networking activities.
  • An ability to advertise one page in the distribution of abstract books and flyers that ultimately gets 1 million views and adds great value to your research profile.
  • Learn a transition beyond your area of interest to learn more about new subjects and studies away from your core subject of HIV-Aids and STD's We have distinctive networking, learning and enjoyable integration into a single package.

To Collaborate Scientific Professionals around the World

Conference Date January 03-04, 2023

For Sponsors & Exhibitors

sponsor@conferenceseries.com

Speaker Opportunity

Supported By

All accepted abstracts will be published in respective Conference Series International Journals.

Abstracts will be provided with Digital Object Identifier by


Keytopics

  • AIDS Stigma And Discrimination
  • Bacterial Infections
  • Chronic HIV
  • Clinical Latency
  • Complementary Therapies
  • Drug Interactions
  • Drug Resistant Strains
  • Effective HIV Treatment
  • ELISA
  • Emerging Technologies Towards HIV/AIDS
  • Fungal Infections
  • Generic Drugs
  • Health Issues In Aging HIV
  • HIV & Vaccines
  • HIV & Vaccines
  • HIV & Vaccines
  • HIV And Aging
  • HIV And AIDS Nursing Care Management
  • HIV And Bone Damage
  • HIV And Bone Damage
  • HIV And Bone Damage
  • HIV And Cardiovascular Disease
  • HIV And Retroviral Diseases
  • HIV Criminalization
  • HIV Diagnosis And Therapy
  • HIV Drug Chart (Overview)
  • HIV Drug Discovery And Research
  • HIV In Women
  • HIV In Women
  • HIV In Women
  • HIV Infection
  • HIV Latency
  • HIV Treatment As Prevention (TasP)
  • HIV/AIDS Nursing And AIDS Awareness
  • Key Topices For Hiv And Aids
  • Lived Experience Of HIV
  • MSM
  • Pediatric HIV AIDS
  • Perinatal Transmission
  • Screening For HIV Infection
  • Seroconversion
  • Stage Of HIV Infection
  • Stage Of HIV Infection
  • Stigma
  • Transmitted Resistance
  • Treatment For HIV
  • Vaccination Therapy
  • Vaccines Development
  • Venereal Diseases Prevention And Treatment
  • Viral Immunology
  • Viral Infections
  • Viral Suppression
  • Western Blot Test
  • What Is HIV
  • What Is HIV
  •  effective HIV Treatment